Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.JGO.2024.101709 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Introduction: The Sustainable Development Goals of the United Nations include a commitment to “leave no one behind” as a universal goal. To achieve this in geriatric oncology (GO) worldwide, it is important to understand the current state of GO at an international level. The International Society of Geriatric Oncology (SIOG) has several National Representatives (NRs) who act as SIOG's delegates in their respective countries. The NRs took part in this international survey exploring the state of GO practice, identifying barriers and solutions. Materials and Methods: The NRs answered open-ended questions by email from February 2020 to October 2022. The questionnaire domains included the demographic information of older adults for their countries, and the NRs' opinions on whether GO is developing, what the barriers are to developing GO, and proposed actions to remove these barriers. The demographic data of each country reported in the survey was adjusted using literature and database searches. Results: Twenty-one of thirty countries with NRs (70%) participated in this questionnaire study: 12 European, four Asian, two North American, two South American, and one Oceanian. The proportion of the population aged ≥75 years varied from 2.2% to 15.8%, and the average life expectancy also varied from 70 years to 86 years. All NRs reported that GO was developing in their country; four NRs (18%) reported that GO was well developed. Although all NRs agreed that geriatric assessment was useful, only three reported that it was used day-to-day in their countries' clinical practice (14%). The major barriers identified were the lack of (i) evidence to support GO use, (ii) awareness and interest in GO, and (iii) resources (time, manpower, and funding). The major proposed actions were to (i) provide new evidence through clinical trials specific for GO patients, (ii) stimulate awareness through networking, and (iii) deliver educational materials and information to healthcare providers and medical students. Discussion: This current survey has identified the barriers to GO and proposed actions that could remove them. Broader awareness seems to be essential to implementing GO. Additional actions are needed to develop GO within countries and can be supported through international partnerships.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Mizutani, Tomonori | - |
Kyorin University Faculty of Medicine - Japón
Kyorin Univ - Japón |
| 2 | Cheung, Kwok Leung | - |
University of Nottingham Medical School - Reino Unido
Univ Nottingham - Reino Unido |
| 3 | Hakobyan, Yervand | - |
Hematology and Transfusion Medicine department of NIH Armenia - Armenia
Hematol Ctr Prof Yeolyan - Armenia |
| 4 | Lane, Heather | - |
Sir Charles Gairdner Hospital - Australia
Sir Charles Gairdner Hosp - Australia |
| 5 | Decoster, Lore | - |
Universitair Ziekenhuis Brussel - Bélgica
Vrije Univ Brussel - Bélgica |
| 6 | Karnakis, Theodora | - |
Universidade de São Paulo - Brasil
State Sao Paulo Univ - Brasil |
| 7 | Puts, Martine | Mujer |
University of Toronto - Canadá
UNIV TORONTO - Canadá |
| 8 | Calderon, Oscar | Hombre |
Clínica Alemana - Chile
Clin Alemana de Santiago & Complejo Asistencial Dr - Chile |
| 9 | Jørgensen, Trine L. | - |
Odense Universitetshospital - Dinamarca
Odense Univ Hosp - Dinamarca |
| 10 | Boulahssass, Rabia | - |
Centre Hospitalier Universitaire de Nice - Francia
Univ Hosp Nice - Francia |
| 11 | Wedding, Ulrich | - |
Universitätsklinikum Jena und Medizinische Fakultät - Alemania
Univ Hosp Jena - Alemania |
| 12 | Karampeazis, Athanasios | - |
Veterans Hospital (NIMTS) - Grecia
NIMTS Veterans Hosp - Grecia |
| 13 | Chan, Wendy Wing Lok | - |
The University of Hong Kong - Hong Kong
Univ Hong Kong - China |
| 14 | Banerjee, Joyita | - |
All India Institute of Medical Sciences, New Delhi - India
All India Inst Med Sci - India |
| 15 | Falci, Cristina | - |
Istituto Oncologico Veneto IOV - IRCCS - Italia
Veneto Inst Oncol IOV - Italia |
| 16 | Van Leeuwen, Barbara L. | - |
Universitair Medisch Centrum Groningen - Países Bajos
Univ Med Ctr Groningen - Países Bajos |
| 17 | Fonseca, Vasco | - |
Centro Hospitalar de Lisboa Ocidental - Portugal
Ctr Hosp Lisboa Ocidental - Portugal |
| 18 | Gironés Sarrió, Regina | Mujer |
Hospital Universitari i Politècnic La Fe - España
|
| 18 | Sarrio, Regina Girones | - |
Hosp Univ & Politecn La Fe - España
Hospital Universitari i Politècnic La Fe - España |
| 19 | Vetter, Marcus | - |
Kantonsspital Liestal - Suiza
Kantonsspital Baselland - Suiza |
| 20 | Dougoud, Vérène | - |
HFR - Suiza
HFR Hosp - Suiza |
| 21 | Naeim, Arash | - |
UCLA Samueli School of Engineering - Estados Unidos
UCLA - Estados Unidos Samueli Sch Engn & Appl Sci - Estados Unidos |
| 22 | Ashman, Jed | - |
Birmingham City Hospital - Reino Unido
International Society of Geriatric Oncology - Suiza Sandwell & West Birmingham NHS Trust - Reino Unido Int Soc Geriatr Oncol - Suiza |
| 23 | Musolino, Najia | - |
International Society of Geriatric Oncology - Suiza
Int Soc Geriatr Oncol - Suiza |
| 24 | Kanesvaran, Ravindran | - |
National Cancer Centre, Singapore - Singapur
Natl Canc Ctr Singapore - Singapur |